Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Daiwa: LG Chem’s Q1 earnings expected to be minimally affected by Middle East conflict

Daiwa: LG Chem’s Q1 earnings expected to be minimally affected by Middle East conflict

格隆汇格隆汇2026/03/24 02:28
Show original
Dahe Capital’s Henny Jung and Yoonki Bae stated on March 24th via Gelonghui that LG Chem’s earnings in the first quarter are expected to be only modestly affected by the conflict in the Middle East. The analysts wrote in their report that geopolitical tensions have sparked expectations of a short-term naphtha shortage, and the potential supply shortage of petrochemical products has recently pushed up the sector’s stock prices. However, they cautioned that the fundamentals of petrochemical products remain weak, with only moderate improvement anticipated in the first quarter. They pointed out that the South Korean chemical company holds about a month’s worth of naphtha inventory, and procurement difficulties could lead to decreased plant utilization in the second quarter. They warned against overly optimistic sentiment.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Novartis (NVS.US) cardiovascular therapy trial "misfire" drags down Amgen (AMGN.US): stock price plunges to a ten-year low, BMO swiftly downgrades rating

Amgen's stock posted its biggest single-day decline since 2016 on Tuesday, after Novartis announced that a heart disease therapy jointly developed with Ionis Pharmaceuticals suffered a setback in late-stage clinical trials. Meanwhile, BMO downgraded the pharmaceutical giant's rating from "Outperform" to "Market Perform," citing the failure of its candidate drug pelacarsen to meet expectations in its phase III clinical trial.

智通财经2026/09/09 08:11
Novartis (NVS.US) cardiovascular therapy trial "misfire" drags down Amgen (AMGN.US): stock price plunges to a ten-year low, BMO swiftly downgrades rating

NASA contractor Rothe Development rushes to Nasdaq, plans to raise $50 millions

Rothe Development, a contractor that provides engineering and mission operations services to NASA and other federal agencies, filed on Tuesday with the SEC to raise up to $50 million through an initial public offering (IPO).

智通财经2026/09/09 08:11
NASA contractor Rothe Development rushes to Nasdaq, plans to raise $50 millions